Ligand validation:2WGZ

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 2WGZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WGZ_GAL_B_1204	52%	57%	0.124	0.897	0.87	0.8	-	-	0	0	92%	0.9167
1GX0_GAL_B_1371	2%	18%	0.475	0.737	2.14	1.42	3	3	1	0	100%	1
1G93_GAL_A_502	1%	38%	0.573	0.747	0.75	1.67	-	1	0	0	100%	0.9167
8VCS_GAL_G_301	100%	29%	0.025	0.993	0.95	1.87	-	3	2	0	100%	1
4WWH_GAL_A_401	100%	64%	0.026	0.99	0.47	0.9	-	-	0	0	100%	1
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.